The U.S. hormone replacement therapy market size was valued at USD 10.2 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. The rising incidence of various hormonal imbalance disorders and the increasing population of geriatric and... Read More »
November 2020The global systemic scleroderma treatment market size was valued at USD 1.4 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2020 to 2027. The supplemental approvals for existing treatment options coupled with the emergence of first-in-class ... Read More »
November 2020The introduction of a safe and effective product by 2021 seems highly possible as multiple candidates have entered Phase II trials. Unprecedented research efforts, in terms of both speed and scale, by hundreds of research groups are anticipated to bring a fundamental and necessary change... Read More »
October 2020The global burn ointment market size was valued at USD 813.7 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.1% from 2020 to 2027. Favorable reimbursement policies, technological advancements, and the rising incidence of burn cases are some of the key... Read More »
September 2020The Germany pharmaceuticals market size was valued at USD 41.4 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2020 to 2027. Increasing patent applications that are focused on the development of novel drug delivery systems, new drugs, and form... Read More »
September 2020The North and South America mineral supplement tablets market size was valued at USD 2.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2020 to 2027. Rising prevalence of diseases such as osteoporosis, anemia, cancer, and diabetes is boosting... Read More »
May 2020The COVID-19 outbreak caused due to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), affecting millions of people globally. The outbreak of the pandemic COVID-19 has impelled the pharmaceutical industry into action, with a race to develop both therapeutic and preventive inte...Read More »
The global somatostatin analogs market size was valued at USD 5.5 Billion in 2018 and is expected to grow at a CAGR of 6.3% over the forecast period. Increasing prevalence of Neuroendocrine Tumors (NETs), acromegaly, Cushing syndrome, and other related diseases is expected to accelerate ... Read More »
October 2019The global tumor necrosis factor inhibitor drugs market size was valued at USD 40.4 billion in 2018 and is estimated to expand at a CAGR of 0.5% over the forecast period. The growth is expected to be driven by new product launches, promising pipeline, increasing incidence of autoimmune d... Read More »
July 2019The global psoriatic arthritis treatment market size was valued at USD 8.6 billion in 2018 and is estimated to expand at a CAGR of 10.1% over the forecast period. The promising pipeline, new product launches, increasing disease burden, and a significant rise in consumer awareness are som... Read More »
July 2019Global neglected tropical diseases drugs and vaccines market comprise diseases that affect largely developing countries but due to increased international migration, these diseases are now a concern in developed nations. The London Declaration, signed in 2012, aimed to bring in focus neg...Read More »
The global anti-aging services market size was valued at USD 23.45 billion in 2018. It is poised to expand at a CAGR of 5.3% over the forecast period. The market has been shaped by constantly changing customer demands. Since the majority of the customer base in the market has become soci... Read More »
February 2019The global metabolic disorder therapeutics market size was valued at USD 49.65 billion in 2017 and is expected to register a CAGR of 7.56% over the forecast period. Increasing demand for one-time therapies for metabolic disorders and the rising prevalence of lifestyle diseases are the ke... Read More »
January 2019The global rosacea treatment market size was valued at USD 1.5 billion in 2017. It is anticipated to register a CAGR of 6.8% over the forecast period. The market is consolidated in nature. Proactive government initiatives, advanced formulations, and high disease prevalence are some facto... Read More »
January 2019Global hyperhidrosis treatment market is anticipated to witness significant growth over the forecast period owing to the surge in the incidences of secondary hyperhidrosis condition globally. Rising incidences of secondary hyperhidrosis are associated with sedentary lifestyle, unhealthy ...Read More »
The global food allergy market is anticipated to witness noteworthy growth over the forecast period owing to an alarming rise in the number of food allergies and sensitivities around the globe. Food allergy is an abnormal response caused by food products such as tree nuts, peanut, soy. T...Read More »
The global pompe disease market is expected to witness significant growth through the forecast period. Pompe disease (glycogenosis type II) is a rare disorder affecting approximately 1 in 40,000 people in the U.S. Factors such as continued uptake of long-term therapies, the launch of nov...Read More »
The global neuroendocrine tumor treatment market size was estimated at USD 1.51 billion in 2017 and is expected to register a CAGR of 10.4% during the forecast period. Increasing cases of neuroendocrine tumors (NETs) are expected to accelerate the demand for treatment options, thereby au... Read More »
November 2018The global paroxysmal nocturnal hemoglobinuria (PNH) treatment market size was valued at USD 2.24 billion in 2017. It is expected to exhibit a CAGR of 11.2% during the forecast period. Increasing adoption of novel therapeutics, rising geriatric population, and the emergence of biologics ... Read More »
October 2018The global lysosomal acid lipase deficiency (LAL-D) treatment market size was valued at USD 380 million in 2017. It is expected to exhibit a CAGR of 10.8% during the forecast period. Increasing uptake of enzyme replacement therapy, continued use of supportive care therapies, and high unm... Read More »
October 2018